I guess to get the market excited the burns results will need to...

I guess to get the market excited the burns results will need to be clear and concise and easily understood to the every day investor. Need to explain exactly why the results are of value assuming they are successful. I say that because looking back at the animal trials they seemed to be suggesting bacteria was better than soframycin but soframycun was around 29%, higher dose 327 around 38%? Wound healing aslo didn't appear to be huge difference, just " statistically relevant", not sure what terms they used.
Like when updates on covid ferret tests came out we spent weeks trying to figure if the detailed logarithmic change should be impressive or not.
Hopefully assuming results mirror what they saw in animals they can detail it in such a way that we don't need to understand medical terminology or logarithmic scales.

at the very least hopefully they make a huge deal out of the fact that even if results are only "as good as" standard care that is without the problem of adding to or being hindered by anti biotic resistance, which is a HUGE global issue right now.

My concern is many average punters will be looking for a 0 or 1 result, no good or 100% amazing. Anything between that is not clearly explained may lead to negativity just because the gravity of the results may not be understood.